Stock 300642 TELLGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Tellgen Corporation

Equities

300642

CNE100002P42

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
11.97 CNY -0.42% Intraday chart for Tellgen Corporation -2.21% -32.18%
07/06 Shanghai Maishi Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation CI
15/05 Tellgen Corporation Approves Cash Dividend for 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shanghai Maishi Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
CI
Tellgen Corporation Approves Cash Dividend for 2023
CI
Shanghai Maishi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
CI
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
CI
Tellgen Corporation's Equity Buyback announced on February 6, 2024, has closed with 1,946,150 shares, representing 1.2% for CNY 25.98 million.
CI
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
CI
Tellgen Corporation announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Tellgen Corporation authorizes a Buyback Plan.
CI
Tellgen Corporation Announces Board Appointments
CI
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tellgen Corporation, Shanghai Tellgen Diagnostic Technology Co., Ltd., Shanghai Maishi Jingwu Enterprise Management Partnership Enterprise (Limited Partnership), Yao Beier, Niu Zhengxiang and Zhan Hong agreed to acquire additional 5.71% stake in Shanghai Maishi Biotechnology Co., Ltd. from Wu Liang for CNY 1.4 million.
CI
Tellgen Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tellgen Corporation Approves Cash Dividend for 2022, Payable on 23 May 2023
CI
Tellgen Corporation Proposes Final Cash Dividend for 2022
CI
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
CI
Tellgen Corporation's Equity Buyback announced on October 27, 2021, has expired with 1,062,840 shares, representing 0.65% for CNY 25.43 million.
CI
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300642 Stock
  4. News Tellgen Corporation